These findings suggest that violacein may suppress the cancer stem-like features of HCC cells by inhibiting the expression of key cancer stemness markers, including CD133, Sox2, Oct4, and Nanog, via downregulation of the STAT3/AKT/ERK signaling pathways. Here, STAT3 is linked to hepatocellular carcinoma.